Skip to main content
OpenTrials
Completed

NCT Number: NCT01150305

Epidemiology of Non-syndromic Dominant Deafness

Hearing impairment is a common disorder that affects at least 7% of individuals in our countries. Even the causes of hearing impairment are numerous, genetic causes represent the main factor of sensorineural deafness. Among hereditary non-syndromic deafness autosomal-dominant inheritance is observed in about 10-20% of the cases. These forms of deafness are usually post-lingual and progressive. To date more than 41 chromosomal localisation and 21 genes associated to non syndromic dominant deafness have been described. It represents an extreme genetic heterogeneity making difficult the studies of these forms of hearing impairment. But, genetic diagnostic testing is crucial in these cases. Indeed, therapeutic research are in the way to prevent the progression of the disorder. The aim of this work is to establish the prevalence of the different genes involved in these forms of deafness.

Completed

Looking for future studies?

Notify Me

Key information

Age range

4 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Armand-Trousseau, Service d'ORL pédiatrique et de Chirurgie Maxillo Faciale

Paris, 75012, France

About this study

The protocol consists first in the recruitment of 150 families with non syndromic dominant hearing impairment. The families will be recruited by the clinical investigators. The clinic and radiological characteristics of the hearing impairment will be collected by the clinical investigators. Samples of patients and healthy relatives will be sent to the referral center. A linkage study of the whole genome by SNP studies is in progress in a cohort of large families affected by autosomal dominant deafness. This work will enable us to select the loci that may be frequently implicated in our population and screen these genes in the 150 families included in the protocol.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age > 4 years.
  • Patient presenting familial dominant non syndromic hearing loss starting between 4 and 40 years old, over 2 generations
  • Healthy volunteer from the same families
  • Clinical and paraclinical assessment (genetic and ophthalmologic examination, audiometric tests, inner ear CT scan)
  • Affiliated to the national health insurance benefit
  • Signature of informed consent form

Exclusion criteria

  • hearing loss resulting from an extrinsic reason or an associated syndrome
  • Defective or insufficient samples
  • No or insufficient clinical and biological description
  • No informed consent form

Treatment and study plan

Blood sample

Biological

Peripheral whole blood sample, 5 ml

Primary outcomes

  1. The identification of a deleterious mutation of a gene coding a protein present in the cochlea

    Time frame: 1 day

Secondary outcomes

  1. The phenotype genotype relationships after identification of the causative gene and mutation

    Time frame: 1 day

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Official study title

Genetic Epidemiology of Non-syndromic Dominant Deafness

Acronym: SURDOM

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Jun 24, 2010
Registry last updated
Aug 7, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.